Rare diseases
Investigational molecules
Locations
Ul. Trzy Lipy 3, 80-172 Gdansk, Poland
Research activity includes ulcerative colitis, with a focus on treatments for moderately to severely active disease and the evaluation of gastrointestinal inflammation in clinical settings.
The sponsor’s trial portfolio reflects interest in therapies used to manage persistent bowel inflammation and related symptom control.
Polpharma Biologics S.A. runs clinical trials in conditions such as Colitis ulcerative, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
BulgariaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
